<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Press Coverage

Tezepelumab reduces exacerbations in broad population of patients with severe asthma

Default sub title

Author Healio | Publish Date May 19, 2021

A presenter at the American Thoracic Society International Conference provided an update on the latest clinical evidence from phase 3 studies of tezepelumab in a broad population of patients with severe asthma.